VANCOUVER, BRITISH COLUMBIA--(Marketwired - Aug. 7, 2013) - Response Biomedical Corp. ("Response") (TSX:RBM)(OTCBB:RPBIF) will release its second quarter 2013 financial results after the markets close on August 13, 2013.
Jeffrey L. Purvin, Chief Executive Officer, will host a conference call to discuss the Q2, 2013 financial results on August 13, 2013 at 2:00 p.m. PST (5:00 p.m. EST), shortly after the initial release. Also participating in the call will be Bill Adams, Chief Financial Officer.
The conference call will be webcast live and is also available by dialing 1-877-643-7155 in North America or 1-914-495-8552 for all other locations. The conference ID number is 27515261 and participants are encouraged to initiate their calls at least 10 minutes in advance of the 2:00 p.m. PDT (5:00 p.m. EDT) start time to ensure a timely connection.
The live webcast and earnings release will be accessible from our website: www.responsebio.com/investors/presentations. A replay of the conference call will also be available online approximately two hours after the call and for 90 days thereafter.
Response is a publicly traded company listed on the TSX under the trading symbol "RBM" and quoted on the OTC Bulletin Board under the symbol "RPBIF". For further information, please visit the Company's website at www.responsebio.com.
Contact Information:
W.J. (Bill) Adams
Chief Financial Officer
604-456-6010
ir@responsebio.com
www.responsebio.com